Effect of pulmonary artery denervation in postcapillary pulmonary hypertension: results of a randomized controlled translational study.


Journal

Basic research in cardiology
ISSN: 1435-1803
Titre abrégé: Basic Res Cardiol
Pays: Germany
ID NLM: 0360342

Informations de publication

Date de publication:
11 01 2019
Historique:
received: 17 08 2018
accepted: 27 12 2018
entrez: 13 1 2019
pubmed: 13 1 2019
medline: 14 6 2019
Statut: epublish

Résumé

There is scarce evidence for pulmonary artery denervation (PADN) as a potential treatment for chronic postcapillary pulmonary hypertension (PH). We aimed to perform a proof-of-concept of PADN in a translational model of chronic PH. Nineteen pigs with chronic postcapillary PH (secondary to pulmonary vein banding) were randomized to surgical-PADN (using bipolar radiofrequency clamps) or sham procedure. Additionally, 6 healthy animals underwent percutaneous-PADN to compare the pulmonary artery (PA) lesion generated with both approaches. In the surgical-PADN arm, hemodynamic evaluation and cardiac magnetic resonance (CMR) were performed at baseline and at 2 and 3-month follow-up. Histological assessment was carried out at the completion of the protocol. Eighteen pigs (6 following surgical-PADN, 6 sham and 6 percutaneous-PADN) completed the protocol. A complete transmural PA lesion was demonstrated using surgical clamps, whereas only focal damage to adventitial fibers was observed after percutaneous-PADN. In the surgical-PADN arm, the hemodynamic profile did not significantly differ between groups neither at baseline [mean pulmonary artery pressure (mPAP) median values of 32.0 vs. 27.5 mmHg, P = 0.394 and indexed pulmonary vascular resistance (iPVR) 5.9 vs. 4.7 WU m

Identifiants

pubmed: 30635778
doi: 10.1007/s00395-018-0714-x
pii: 10.1007/s00395-018-0714-x
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5

Auteurs

Ines Garcia-Lunar (I)

Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Hospital Universitario Quirónsalud Madrid, UEM, Madrid, Spain.

Daniel Pereda (D)

Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Clinic Cardiovascular Institute, IDIBAPS, Hospital Clínic, Villarroel 170, 08027, Barcelona, Spain.

Evelyn Santiago (E)

Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
Clinic Cardiovascular Institute, IDIBAPS, Hospital Clínic, Villarroel 170, 08027, Barcelona, Spain.

Nuria Solanes (N)

Clinic Cardiovascular Institute, IDIBAPS, Hospital Clínic, Villarroel 170, 08027, Barcelona, Spain.

Jorge Nuche (J)

Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
Hospital Universitario Doce de Octubre, Madrid, Spain.

María Ascaso (M)

Clinic Cardiovascular Institute, IDIBAPS, Hospital Clínic, Villarroel 170, 08027, Barcelona, Spain.

Joaquim Bobí (J)

Clinic Cardiovascular Institute, IDIBAPS, Hospital Clínic, Villarroel 170, 08027, Barcelona, Spain.

Federico Sierra (F)

Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.

Ana Paula Dantas (AP)

Clinic Cardiovascular Institute, IDIBAPS, Hospital Clínic, Villarroel 170, 08027, Barcelona, Spain.

Carlos Galán (C)

Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Rodolfo San Antonio (R)

Clinic Cardiovascular Institute, IDIBAPS, Hospital Clínic, Villarroel 170, 08027, Barcelona, Spain.

Damián Sánchez-Quintana (D)

Departamento de Anatomía y Biología Celular, Facultad de Medicina, Universidad de Extremadura, Badajoz, Spain.

Javier Sánchez-González (J)

Philips Healthcare Iberia, Madrid, Spain.

Joan Albert Barberá (JA)

CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
Department of Pulmonary Medicine, Hospital Clínic-IDIBAPS, Barcelona, Spain.

Montserrat Rigol (M)

CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Clinic Cardiovascular Institute, IDIBAPS, Hospital Clínic, Villarroel 170, 08027, Barcelona, Spain.

Valentín Fuster (V)

Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, USA.

Borja Ibáñez (B)

Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
IIS-Fundación Jiménez Díaz University Hospital, Madrid, Spain.

Manel Sabaté (M)

Clinic Cardiovascular Institute, IDIBAPS, Hospital Clínic, Villarroel 170, 08027, Barcelona, Spain.

Ana García-Álvarez (A)

Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain. ana.garcia@cnic.es.
CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain. ana.garcia@cnic.es.
Clinic Cardiovascular Institute, IDIBAPS, Hospital Clínic, Villarroel 170, 08027, Barcelona, Spain. ana.garcia@cnic.es.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH